nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilutamide—POR—Doxorubicin—peripheral nervous system neoplasm	0.374	0.551	CbGbCtD
Nilutamide—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.126	0.186	CbGbCtD
Nilutamide—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0879	0.129	CbGbCtD
Nilutamide—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.053	0.0781	CbGbCtD
Nilutamide—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0376	0.0555	CbGbCtD
Nilutamide—Enzalutamide—ABCB1—peripheral nervous system neoplasm	0.00154	1	CrCbGaD
Nilutamide—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000483	0.00151	CcSEcCtD
Nilutamide—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000482	0.00151	CcSEcCtD
Nilutamide—Back pain—Etoposide—peripheral nervous system neoplasm	0.000479	0.0015	CcSEcCtD
Nilutamide—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000478	0.00149	CcSEcCtD
Nilutamide—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000477	0.00149	CcSEcCtD
Nilutamide—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000476	0.00149	CcSEcCtD
Nilutamide—Cardiac failure—Epirubicin—peripheral nervous system neoplasm	0.000472	0.00148	CcSEcCtD
Nilutamide—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000471	0.00147	CcSEcCtD
Nilutamide—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000468	0.00146	CcSEcCtD
Nilutamide—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000468	0.00146	CcSEcCtD
Nilutamide—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000468	0.00146	CcSEcCtD
Nilutamide—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000465	0.00145	CcSEcCtD
Nilutamide—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000462	0.00144	CcSEcCtD
Nilutamide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000461	0.00144	CcSEcCtD
Nilutamide—Gastrointestinal haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000461	0.00144	CcSEcCtD
Nilutamide—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00046	0.00144	CcSEcCtD
Nilutamide—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00046	0.00144	CcSEcCtD
Nilutamide—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000458	0.00143	CcSEcCtD
Nilutamide—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000457	0.00143	CcSEcCtD
Nilutamide—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.000456	0.00143	CcSEcCtD
Nilutamide—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000456	0.00142	CcSEcCtD
Nilutamide—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000455	0.00142	CcSEcCtD
Nilutamide—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000455	0.00142	CcSEcCtD
Nilutamide—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.000452	0.00141	CcSEcCtD
Nilutamide—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000452	0.00141	CcSEcCtD
Nilutamide—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000452	0.00141	CcSEcCtD
Nilutamide—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000451	0.00141	CcSEcCtD
Nilutamide—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00045	0.00141	CcSEcCtD
Nilutamide—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000448	0.0014	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000447	0.0014	CcSEcCtD
Nilutamide—Malaise—Etoposide—peripheral nervous system neoplasm	0.000447	0.0014	CcSEcCtD
Nilutamide—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000443	0.00139	CcSEcCtD
Nilutamide—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000443	0.00138	CcSEcCtD
Nilutamide—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000443	0.00138	CcSEcCtD
Nilutamide—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000441	0.00138	CcSEcCtD
Nilutamide—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000441	0.00138	CcSEcCtD
Nilutamide—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000441	0.00138	CcSEcCtD
Nilutamide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000438	0.00137	CcSEcCtD
Nilutamide—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000437	0.00137	CcSEcCtD
Nilutamide—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000435	0.00136	CcSEcCtD
Nilutamide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000434	0.00136	CcSEcCtD
Nilutamide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000434	0.00136	CcSEcCtD
Nilutamide—Rash—Topotecan—peripheral nervous system neoplasm	0.000434	0.00136	CcSEcCtD
Nilutamide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000434	0.00136	CcSEcCtD
Nilutamide—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000434	0.00136	CcSEcCtD
Nilutamide—Cough—Etoposide—peripheral nervous system neoplasm	0.000432	0.00135	CcSEcCtD
Nilutamide—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000432	0.00135	CcSEcCtD
Nilutamide—Headache—Topotecan—peripheral nervous system neoplasm	0.000432	0.00135	CcSEcCtD
Nilutamide—Rash—Tretinoin—peripheral nervous system neoplasm	0.000431	0.00135	CcSEcCtD
Nilutamide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000431	0.00135	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000431	0.00135	CcSEcCtD
Nilutamide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00043	0.00135	CcSEcCtD
Nilutamide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00043	0.00135	CcSEcCtD
Nilutamide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000429	0.00134	CcSEcCtD
Nilutamide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000428	0.00134	CcSEcCtD
Nilutamide—Headache—Tretinoin—peripheral nervous system neoplasm	0.000428	0.00134	CcSEcCtD
Nilutamide—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000428	0.00134	CcSEcCtD
Nilutamide—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000427	0.00133	CcSEcCtD
Nilutamide—Pain—Vincristine—peripheral nervous system neoplasm	0.000427	0.00133	CcSEcCtD
Nilutamide—Constipation—Vincristine—peripheral nervous system neoplasm	0.000427	0.00133	CcSEcCtD
Nilutamide—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000427	0.00133	CcSEcCtD
Nilutamide—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000427	0.00133	CcSEcCtD
Nilutamide—Rash—Melphalan—peripheral nervous system neoplasm	0.000425	0.00133	CcSEcCtD
Nilutamide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000425	0.00133	CcSEcCtD
Nilutamide—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000423	0.00132	CcSEcCtD
Nilutamide—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000423	0.00132	CcSEcCtD
Nilutamide—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000422	0.00132	CcSEcCtD
Nilutamide—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000421	0.00131	CcSEcCtD
Nilutamide—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000417	0.0013	CcSEcCtD
Nilutamide—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000415	0.0013	CcSEcCtD
Nilutamide—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000409	0.00128	CcSEcCtD
Nilutamide—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000409	0.00128	CcSEcCtD
Nilutamide—Nausea—Topotecan—peripheral nervous system neoplasm	0.000409	0.00128	CcSEcCtD
Nilutamide—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000408	0.00128	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000407	0.00127	CcSEcCtD
Nilutamide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000406	0.00127	CcSEcCtD
Nilutamide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000406	0.00127	CcSEcCtD
Nilutamide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000401	0.00125	CcSEcCtD
Nilutamide—Nausea—Melphalan—peripheral nervous system neoplasm	0.000401	0.00125	CcSEcCtD
Nilutamide—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.0004	0.00125	CcSEcCtD
Nilutamide—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000398	0.00125	CcSEcCtD
Nilutamide—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000396	0.00124	CcSEcCtD
Nilutamide—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000394	0.00123	CcSEcCtD
Nilutamide—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000394	0.00123	CcSEcCtD
Nilutamide—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000393	0.00123	CcSEcCtD
Nilutamide—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000391	0.00122	CcSEcCtD
Nilutamide—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000391	0.00122	CcSEcCtD
Nilutamide—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000388	0.00121	CcSEcCtD
Nilutamide—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000385	0.0012	CcSEcCtD
Nilutamide—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000384	0.0012	CcSEcCtD
Nilutamide—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000384	0.0012	CcSEcCtD
Nilutamide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000382	0.00119	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000381	0.00119	CcSEcCtD
Nilutamide—Pain—Cisplatin—peripheral nervous system neoplasm	0.000377	0.00118	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000376	0.00118	CcSEcCtD
Nilutamide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000372	0.00116	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.00037	0.00116	CcSEcCtD
Nilutamide—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000369	0.00115	CcSEcCtD
Nilutamide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000366	0.00115	CcSEcCtD
Nilutamide—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000364	0.00114	CcSEcCtD
Nilutamide—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000363	0.00113	CcSEcCtD
Nilutamide—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.00036	0.00113	CcSEcCtD
Nilutamide—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00036	0.00113	CcSEcCtD
Nilutamide—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000359	0.00112	CcSEcCtD
Nilutamide—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000359	0.00112	CcSEcCtD
Nilutamide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000358	0.00112	CcSEcCtD
Nilutamide—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000357	0.00112	CcSEcCtD
Nilutamide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000355	0.00111	CcSEcCtD
Nilutamide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000354	0.00111	CcSEcCtD
Nilutamide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000352	0.0011	CcSEcCtD
Nilutamide—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000351	0.0011	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000349	0.00109	CcSEcCtD
Nilutamide—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000349	0.00109	CcSEcCtD
Nilutamide—Constipation—Etoposide—peripheral nervous system neoplasm	0.000346	0.00108	CcSEcCtD
Nilutamide—Pain—Etoposide—peripheral nervous system neoplasm	0.000346	0.00108	CcSEcCtD
Nilutamide—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000345	0.00108	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000343	0.00107	CcSEcCtD
Nilutamide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000342	0.00107	CcSEcCtD
Nilutamide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000341	0.00107	CcSEcCtD
Nilutamide—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000341	0.00106	CcSEcCtD
Nilutamide—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000339	0.00106	CcSEcCtD
Nilutamide—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.00104	CcSEcCtD
Nilutamide—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000333	0.00104	CcSEcCtD
Nilutamide—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000333	0.00104	CcSEcCtD
Nilutamide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000332	0.00104	CcSEcCtD
Nilutamide—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.00103	CcSEcCtD
Nilutamide—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000331	0.00103	CcSEcCtD
Nilutamide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00033	0.00103	CcSEcCtD
Nilutamide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000329	0.00103	CcSEcCtD
Nilutamide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000327	0.00102	CcSEcCtD
Nilutamide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000326	0.00102	CcSEcCtD
Nilutamide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000324	0.00101	CcSEcCtD
Nilutamide—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.00032	0.000999	CcSEcCtD
Nilutamide—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00032	0.000999	CcSEcCtD
Nilutamide—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00032	0.000999	CcSEcCtD
Nilutamide—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.000999	CcSEcCtD
Nilutamide—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000317	0.000992	CcSEcCtD
Nilutamide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000317	0.000992	CcSEcCtD
Nilutamide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000317	0.00099	CcSEcCtD
Nilutamide—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.000985	CcSEcCtD
Nilutamide—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000315	0.000985	CcSEcCtD
Nilutamide—Rash—Vincristine—peripheral nervous system neoplasm	0.000315	0.000983	CcSEcCtD
Nilutamide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000314	0.000983	CcSEcCtD
Nilutamide—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000314	0.000982	CcSEcCtD
Nilutamide—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.00098	CcSEcCtD
Nilutamide—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000313	0.000977	CcSEcCtD
Nilutamide—Headache—Vincristine—peripheral nervous system neoplasm	0.000313	0.000977	CcSEcCtD
Nilutamide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000308	0.000962	CcSEcCtD
Nilutamide—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000307	0.000961	CcSEcCtD
Nilutamide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000302	0.000944	CcSEcCtD
Nilutamide—Nausea—Vincristine—peripheral nervous system neoplasm	0.000296	0.000927	CcSEcCtD
Nilutamide—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.000925	CcSEcCtD
Nilutamide—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000918	CcSEcCtD
Nilutamide—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.000911	CcSEcCtD
Nilutamide—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.000909	CcSEcCtD
Nilutamide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00029	0.000907	CcSEcCtD
Nilutamide—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000289	0.000904	CcSEcCtD
Nilutamide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000286	0.000894	CcSEcCtD
Nilutamide—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.000889	CcSEcCtD
Nilutamide—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000282	0.000881	CcSEcCtD
Nilutamide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000281	0.000877	CcSEcCtD
Nilutamide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000278	0.00087	CcSEcCtD
Nilutamide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000278	0.000869	CcSEcCtD
Nilutamide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000277	0.000865	CcSEcCtD
Nilutamide—Tension—Epirubicin—peripheral nervous system neoplasm	0.000272	0.000852	CcSEcCtD
Nilutamide—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00027	0.000843	CcSEcCtD
Nilutamide—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000269	0.000839	CcSEcCtD
Nilutamide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000267	0.000836	CcSEcCtD
Nilutamide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000262	0.000819	CcSEcCtD
Nilutamide—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000815	CcSEcCtD
Nilutamide—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000258	0.000805	CcSEcCtD
Nilutamide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000257	0.000803	CcSEcCtD
Nilutamide—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000802	CcSEcCtD
Nilutamide—Rash—Etoposide—peripheral nervous system neoplasm	0.000255	0.000797	CcSEcCtD
Nilutamide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000255	0.000796	CcSEcCtD
Nilutamide—Headache—Etoposide—peripheral nervous system neoplasm	0.000253	0.000792	CcSEcCtD
Nilutamide—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000788	CcSEcCtD
Nilutamide—Malaise—Epirubicin—peripheral nervous system neoplasm	0.00025	0.000783	CcSEcCtD
Nilutamide—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.00078	CcSEcCtD
Nilutamide—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000249	0.000778	CcSEcCtD
Nilutamide—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000249	0.000777	CcSEcCtD
Nilutamide—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000777	CcSEcCtD
Nilutamide—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000244	0.000763	CcSEcCtD
Nilutamide—Cough—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000757	CcSEcCtD
Nilutamide—Nausea—Etoposide—peripheral nervous system neoplasm	0.00024	0.000751	CcSEcCtD
Nilutamide—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.00024	0.000749	CcSEcCtD
Nilutamide—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000745	CcSEcCtD
Nilutamide—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000742	CcSEcCtD
Nilutamide—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000236	0.000739	CcSEcCtD
Nilutamide—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000234	0.00073	CcSEcCtD
Nilutamide—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000724	CcSEcCtD
Nilutamide—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000231	0.000723	CcSEcCtD
Nilutamide—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.00072	CcSEcCtD
Nilutamide—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.000719	CcSEcCtD
Nilutamide—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000708	CcSEcCtD
Nilutamide—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000706	CcSEcCtD
Nilutamide—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000701	CcSEcCtD
Nilutamide—Shock—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000697	CcSEcCtD
Nilutamide—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000693	CcSEcCtD
Nilutamide—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000685	CcSEcCtD
Nilutamide—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000684	CcSEcCtD
Nilutamide—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000675	CcSEcCtD
Nilutamide—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000675	CcSEcCtD
Nilutamide—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.000669	CcSEcCtD
Nilutamide—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000655	CcSEcCtD
Nilutamide—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000645	CcSEcCtD
Nilutamide—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000641	CcSEcCtD
Nilutamide—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000636	CcSEcCtD
Nilutamide—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000634	CcSEcCtD
Nilutamide—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000631	CcSEcCtD
Nilutamide—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000625	CcSEcCtD
Nilutamide—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000623	CcSEcCtD
Nilutamide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000616	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000611	CcSEcCtD
Nilutamide—Pain—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000606	CcSEcCtD
Nilutamide—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000606	CcSEcCtD
Nilutamide—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000593	CcSEcCtD
Nilutamide—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000588	CcSEcCtD
Nilutamide—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000584	CcSEcCtD
Nilutamide—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000584	CcSEcCtD
Nilutamide—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000579	CcSEcCtD
Nilutamide—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000577	CcSEcCtD
Nilutamide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.00057	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000566	CcSEcCtD
Nilutamide—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.00056	CcSEcCtD
Nilutamide—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.00056	CcSEcCtD
Nilutamide—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000179	0.00056	CcSEcCtD
Nilutamide—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000179	0.00056	CcSEcCtD
Nilutamide—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.00054	CcSEcCtD
Nilutamide—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000536	CcSEcCtD
Nilutamide—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000518	CcSEcCtD
Nilutamide—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000518	CcSEcCtD
Nilutamide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000508	CcSEcCtD
Nilutamide—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000501	CcSEcCtD
Nilutamide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000485	CcSEcCtD
Nilutamide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.00047	CcSEcCtD
Nilutamide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000468	CcSEcCtD
Nilutamide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000464	CcSEcCtD
Nilutamide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000144	0.00045	CcSEcCtD
Nilutamide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000448	CcSEcCtD
Nilutamide—Rash—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000447	CcSEcCtD
Nilutamide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000446	CcSEcCtD
Nilutamide—Headache—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000444	CcSEcCtD
Nilutamide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000433	CcSEcCtD
Nilutamide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000421	CcSEcCtD
Nilutamide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000417	CcSEcCtD
Nilutamide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000413	CcSEcCtD
Nilutamide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000413	CcSEcCtD
Nilutamide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000411	CcSEcCtD
Nilutamide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000389	CcSEcCtD
